Case Presentation:

Cronkhite‐Canada syndrome (CCS) is a rare sporadic disorder comprising of generalized gastrointestinal polyps, cutaneous pigmentation, alopecia, and onychodystrophy. We present a unique case of CCS syndrome likely precipitated by mycobacterium tuberculosis (MTB) infection.

A 47‐year‐old male from Marshall Islands presented with nausea, vomiting and watery diarrhea for a period of 6‐8 weeks with occasional melanotic stools. He reported generalized weakness, weight loss and decreased appetite. His past history was significant for pulmonary tuberculosis complicated by pericarditis and he had completed an oral multidrug treatment regimen for MTB two months prior to presentation. On presentation he was afebrile and hypotensive. Physical exam revealed a thin built male, with dry oral mucosa, and alopecia. Hyperpigmented macules covered the majority of his head, face, trunk, and extremities. The nails were thickened and dystrophic with yellow pigmentation. Enteroscopy revealed multiple polyps throughout the gastrointestinal tract with biopsies consistent with hyperplastic mucosa and lamina propria edema involving the stomach, ileus and colon. He was found to be MTB positive on induced sputum during this admission. With his diarrhea, it was speculated that he may have erratic absorption of his anti‐tuberculosis medication or else could have multidrug resistant MTB. A regimen composed of rifampin, amikacin and moxifloxacin was initiated during this hospital admission. Given his clinical findings, a diagnosis of Cronkhite‐Canada syndrome was made. He was initiated on oral steroids, with improvement in his gastrointestinal symptoms.

Discussion:

CCS comprises of characteristic skin and nail changes and gastrointestinal polyps. CCS syndrome is postulated to be an autoimmune phenomenon brought on by physical stress. There is resultant local inflammatory reaction in the gastrointestinal tract with formation of hamartomatous polyps. Malabsorption can be another prominent finding. Five year mortality rates range from 40‐60 percent, with most deaths secondary to nutritional malabsorption, recurrent infections, GI bleeding, sepsis, and congestive heart failure. Steroids have been shown to help with symptoms.

Conclusions:

Close follow‐up is needed for electrolyte corrections, prevention of nutritional deficiencies and observation/surveillance of possible malignant potential of the polyps or gastrointestinal bleeding.